
|Articles|August 5, 2014
Venn Life Sciences Acquires French CRO
Venn Life Sciences announced the acquisition of Cardinal Systems SAS
Advertisement
Venn Life Sciences, a CRO based in Europe, announced the acquisition of Cardinal Systems SAS, a France based CRO specializing in data management and randomization systems. The acquisition extends Venn’s service offering into those two areas, and strengthens the company’s position as a full-service European CRO.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AI-Driven Clinical Trial Recruitment and Design
2
What Clinical Trials Can Learn from the Gig Economy About Payments
3
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
4
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
5




